Sandra A. O’Toole

4.7k total citations
29 papers, 1.4k citations indexed

About

Sandra A. O’Toole is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sandra A. O’Toole has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Sandra A. O’Toole's work include Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (4 papers). Sandra A. O’Toole is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (4 papers). Sandra A. O’Toole collaborates with scholars based in Australia, United States and Finland. Sandra A. O’Toole's co-authors include Ewan K.A. Millar, Wendy A. Cooper, Richard A. Scolyer, Catriona M. McNeil, Christina Selinger, Bing Yu, Trina Lum, Robert L. Sutherland, Peter Graham and Lois Browne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sandra A. O’Toole

28 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sandra A. O’Toole

Since Specialization

Citations

This map shows the geographic impact of Sandra A. O’Toole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A. O’Toole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A. O’Toole more than expected).

Fields of papers citing papers by Sandra A. O’Toole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A. O’Toole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A. O’Toole. The network helps show where Sandra A. O’Toole may publish in the future.

Co-authorship network of co-authors of Sandra A. O’Toole

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A. O’Toole. A scholar is included among the top collaborators of Sandra A. O’Toole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A. O’Toole. Sandra A. O’Toole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Annotation-efficient deep learning for breast cancer whole-slide image classification using tumour infiltrating lymphocytes and slide-level labels 2024 ·SHILAP Revista de lepidopterología ·Rashindrie Perera, Peter Savas, (unknown), Roberto Salgado, Heikki Joensuu, Sandra A. O’Toole, Jason Li, Sherene Loi, Saman Halgamuge	4
2	Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation 2020 ·Pathology ·Elizabeth C. Paver, Wendy A. Cooper, Andrew J. Colebatch, Peter M. Ferguson, (unknown), Trina Lum, Joo‐Shik Shin, Sandra A. O’Toole, Lyndal Anderson, Richard A. Scolyer, Ruta Gupta	170
3	Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients 2020 ·Histopathology ·Tanja Jankovic‐Karasoulos, Tina Bianco‐Miotto, Miriam Butler, Lisa M. Butler, Catriona M. McNeil, Sandra A. O’Toole, Ewan K.A. Millar, Andrew J. Sakko, (unknown), Stephen N. Birrell, Robert L. Sutherland, Theresa E. Hickey, Wayne D. Tilley, Carmela Ricciardelli	25
4	Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms 2018 ·Head and Neck Pathology ·Peter P. Luk, Christina Selinger, Wendy A. Cooper, Annabelle Mahar, Carsten E. Palme, Sandra A. O’Toole, Jonathan R. Clark, Ruta Gupta	4
5	Brocade: The National Breast Cancer Foundation Repository of Primary Tumours and Metastases from Breast Cancer Patients 2017 ·Asia-Pacific Journal of Clinical Oncology ·Robin L. Anderson, Alexander Swarbrick, Ricky W. Johnstone, Boon Tin Chua, Anthony J. Gill, Christobel Saunders, Sunil R. Lakhani, Elgene Lim, Sherene Loi, Sandra A. O’Toole, Kum Kum Khanna, Lisa Devereux, Kate Harvey, Amy E. McCart Reed	1
6	Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma 2017 ·Modern Pathology ·(unknown), (unknown), Bing Yu, Bruce Ashford, (unknown), Marie Ranson, Kerwin F. Shannon, Mark J. Cowley, N. Gopalakrishna Iyer, Carsten E. Palme, Sydney Ch’ng, Tsu‐Hui Low, Sandra A. O’Toole, Jonathan R. Clark, Ruta Gupta	37
7	Andy’s Algorithms: new automated digital image analysis pipelines for FIJI 2017 ·Scientific Reports ·Andrew M. K. Law, Julia Yin, Lesley Castillo, Adelaide I.J. Young, Catherine Piggin, Samuel Rogers, Catherine E Caldon, Andrew Burgess, Ewan K.A. Millar, Sandra A. O’Toole, David Gallego‐Ortega, Christopher J. Ormandy, Samantha R. Oakes	37
8	PO-24 - Determinants of thrombin generation in gynaecological malignancies 2016 ·Thrombosis Research ·Lucy Norris, Frédéric Martin, Sandra A. O’Toole, Feras Abu Saadeh, Noreen Gleeson	3
9	The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer. 2015 ·PubMed ·Shu Wang, Bing Yu, (unknown), (unknown), Christina Selinger, Sandra A. O’Toole, Wendy A. Cooper	34
10	PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma 2015 ·Lung Cancer ·Wendy A. Cooper, Trần Nam Thắng, Ricardo E. Vilain, Jason Madore, Christina Selinger, Maija R.J. Kohonen‐Corish, Po Yee Yip, Bing Yu, Sandra A. O’Toole, Brian C. McCaughan, Jennifer H. Yearley, Lisa G. Horvath, Steven Kao, Michael Boyer, Richard A. Scolyer	236
11	A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma 2014 ·The American Journal of Surgical Pathology ·Angela Chou, Sheila Fraser, Christopher W. Toon, Adele Clarkson, Loretta Sioson, Mahtab Farzin, (unknown), Ahmad Aniss, Christine J. O’Neill, Nicole Watson, Roderick Clifton‐Bligh, Diana Learoyd, Bruce G. Robinson, Christina Selinger, Leigh Delbridge, Stanley Sidhu, Sandra A. O’Toole, Mark Sywak, Anthony J. Gill	77
12	Patterns of DNA Mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma 2013 ·Journal of Thoracic Oncology ·Po Yee Yip, Bing Yu, Wendy A. Cooper, Christina Selinger, (unknown), Catherine Kennedy, Maija R.J. Kohonen‐Corish, Brian C. McCaughan, Ronald J. Trent, Michael Boyer, James G. Kench, Lisa G. Horvath, Sandra A. O’Toole	36
13	Intrapatient Homogeneity of BRAFV600E Expression in Melanoma 2013 ·The American Journal of Surgical Pathology ·Alexander M. Menzies, Trina Lum, James S. Wilmott, Jessica Hyman, Richard Kefford, John F. Thompson, Sandra A. O’Toole, Georgina V. Long, Richard A. Scolyer	59
14	β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression 2013 ·Cancer Research ·Babette Schade, Robert Lesurf, Virginie Sanguin‐Gendreau, Tung Bui, Geneviève Deblois, Sandra A. O’Toole, Ewan K.A. Millar, (unknown), Elena López‐Knowles, Robert L. Sutherland, Vincent Giguère, Michaël Kahn, Michael Hallett, William J. Muller	71
15	Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance 2013 ·Journal of Dermatological Case Reports ·Rebecca B. Saunderson, Roger Garsia, (unknown), Geoffrey W. McCaughan, Sandra A. O’Toole, Simone I. Strasser	1
16	Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53 2011 ·British Journal of Cancer ·Ewan K.A. Millar, Peter Graham, Catriona M. McNeil, Lois Browne, Sandra A. O’Toole, Alice Boulghourjian, John H. Kearsley, George Papadatos, Geoff P. Delaney, C Fox, Elias Nasser, Anne Capp, Robert L. Sutherland	55
17	The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy 2009 ·British Journal of Cancer ·Ern Yu Tan, (unknown), Leticia Campo, Chengcheng Han, Elena A. Takano, Helen Turley, Ida Candiloro, Francesco Pezzella, Kevin C. Gatter, Ewan K.A. Millar, Sandra A. O’Toole, Catriona M. McNeil, Paul Crea, Davendra Segara, R. Sutherland, Adrian L. Harris, Stephen B. Fox	165
18	Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel 2009 ·Journal of Clinical Oncology ·Ewan K.A. Millar, Peter Graham, Sandra A. O’Toole, Catriona M. McNeil, Lois Browne, Adrienne Morey, Sarah A. Eggleton, Julia Beretov, (unknown), Anne Capp, Elias Nasser, John H. Kearsley, Geoff P. Delaney, George Papadatos, C Fox, Robert L. Sutherland	247
19	PI3K Pathway Activation in Breast Cancer Is Associated with the Basal-Like Phenotype and Cancer-Specific Mortality. 2009 ·Cancer Research ·Elena López‐Knowles, Sandra A. O’Toole, Sandra O’Toole, Catriona M. McNeil, Ewan K.A. Millar, Min Qiu, Min Qiu, Paul Crea, (unknown), (unknown), Elizabeth A. Musgrove, R. Sutherland, R. L. Sutherland	13
20	Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome 2009 ·Oncogene ·Ewan K.A. Millar, Jeffry L. Dean, Catriona M. McNeil, Sandra A. O’Toole, Susan M. Henshall, Thai H. Tran, (unknown), Andrew A. Quong, Clay E.S. Comstock, Agnieszka K. Witkiewicz, Elizabeth A. Musgrove, Hallgeir Rui, Loı̈c Le Marchand, Veronica Wendy Setiawan, C.A. Haiman, Karen E. Knudsen, R. Sutherland, Erik S. Knudsen	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact